Mauricio Rojas, Silke Meiners, Claude Jourdan Le Saux

Molecular Aspects of Aging (eBook, PDF)

Understanding Lung Aging

• Format: PDF

Produktbeschreibung

Molecular Aspects of Aging: Understanding Lung Aging covers recent research in the mechanisms that contribute to cellular senescence. Covering universal themes in aging, such as the exhaustion of stem cells and subsequent loss of the regenerative refueling of organs as well as immunosenescence, this text illuminates new directions for research not yet explored in the still poorly investigated area of molecular mechanisms of lung aging. The molecular nature of general aging processes is explored with targeted coverage on how to analyze lung aging through experimental approaches.

---

Dieser Download kann aus rechtlichen Gründen nur mit Rechnungsadresse in D ausgeliefert werden.

Produktdetails

• Verlag: John Wiley & Sons
• Erscheinungstermin: 10. März 2014
• Englisch
• ISBN-13: 9781118396278
• Artikelnr.: 40614546

Autorenporträt

Dr. Mauricio Rojas is an Assistant Professor in the Division of Pulmonary, Allergy and Critical Care Medicine, Department of Medicine, University of Pittsburgh.

Silke Meiners, PhD is a Research Group Leader from the Comprehensive Pneumology Center in Munich.

Claude Jourdan Le Saux, PhD is an Assistant Professor in the Department of Medicine Division of Cardiology/Pulmonary and Critical Care, University of Texas Health Science Center at San Antonio, San Antonio, Texas, as well as a faculty member of the Barshop Institute for Longevity and Aging Studies Nathan Shock Aging Center of Excellence and Department of Cellular and Structural Biology.

Inhaltsangabe

Contributors xi
Preface xiii
1 The Demography of Aging 1
David E. Bloom and Sinead Shannon
1.1 Introduction 1
1.2 Demographic trends 1
1.2.1 Fertility rates 2
1.2.2 Mortality rates and life expectancy 2
1.2.3 Proportion of older people 3
1.3 Impact of aging 4
1.3.1 Noncommunicable disease trends 4
1.3.2 Risk factors 5
1.3.3 Impact of NCDs on health and disability 6
1.3.4 Increase in multimorbidities 7
1.3.5 Impact on expenditure 7
1.4 Policy responses 8
1.4.1 Preventing and managing NCDs 8
1.4.2 Promoting exercise 9
1.4.3 Monitoring health-risk behaviors (and chronic health conditions) 9
1.5 Conclusion 9
References 10
2 The Omics of Aging: Insights from Genomes upon Stress 13
Ismene Karakasilioti, Anna Ioannidou, and George A. Garinis
2.1 Introduction 13
2.2 Safeguarding the nuclear genome 14
2.3 NER progerias and their connection to lifespan regulatory mechanisms 15
2.4 Triggering a survival response in the absence of a DNA repair defect 16
2.5 The omics connection between progeria and longevity 19
2.6 Triggering of systemic versus cell-autonomous features of the survival
response 20
2.7 The omics connection between NER progeria, transcription, and longevity
21
2.8 Future perspectives 22
References 22
3 Protein Quality Control Coming of Age 27
Silke Meiners
3.1 Introduction 27
3.2 The aging molecular chaperone network 29
3.3 Protein degradation pathways in aging 30
3.3.1 Lysosomal autophagy pathway 30
3.3.2 Ubiquitin-proteasome system 32
3.4 Compartment-specific protein quality control 34
3.4.1 The aging ER stress response 34
3.5 Conclusion 35
References 35
4 Telomerase Function in Aging 41
Rodrigo T. Calado
4.1 Telomeres 41
4.2 Telomerase 43
4.3 Telomeres and human disease 45
4.3.1 Telomere dysfunction in the lungs 46
4.4 Telomeres biology, aging, and longevity 47
4.5 Conclusion 48
References 48
5 The Cellular Senescence Program 53
Pooja Shivshankar and Claude Jourdan Le Saux
5.1 Cellular senescence and evidence of senescence in a cell 53
5.1.1 Characteristics of senescent cells and the inflammatory
microenvironment 53
5.1.2 Detection of senescent cells in vitro and in vivo 54
5.2 Conditions associated with cellular senescence 55
5.2.1 Oxidative stress 55
5.2.2 DNA damage 55
5.2.3 Cell cycle arrest and senescence 56
5.3 Mechanisms/pathways of senescence induction 56
5.3.1 The p53/p21 pathway 56
5.3.2 The p16/pRB pathway 57
5.3.3 Convergence/coactivation of p53/p21 and p16/pRB pathways 57
5.3.4 Induction of senescence via molecular signaling 57
5.4 Cellular senescence in aging and age-related diseases of the lungs 58
5.4.1 Normal aging 59
5.4.2 Pneumonia 59
5.4.3 Chronic obstructive pulmonary disease 60
5.4.4 Idiopathic pulmonary fibrosis 60
5.5 Conclusion 61
References 61
6 Signaling Networks Controlling Cellular Senescence 67
Leena P. Desai, Yan Y. Sanders, and Victor J. Thannickal
6.1 Introduction 67
6.2 Classification of cellular senescence 69
6.2.1 Intrinsic pathway 69
6.2.2 Extrinsic pathway 69
6.2.3 Reversibility of cellular senescence 70
6.3 Cross talk of signaling pathways 70
6.3.1 Protein kinases 70
6.3.2 Metabolic pathways 71
6.3.3 Mitochondria and reactive oxygen species 71
6.3.4 Integrin and focal adhesion signaling 72
6.3.5 Transforming growth factor-ß1 73
6.3.6 Epigenetic mechanisms 73
6.4 Conclusion 76
References 77
7 Immune Senescence 85
Kevin P. High
7.1 Introduction 85
7.2 Barrier defenses and innate immunity in older adults 86
7.2.1 Barrier defenses 86
7.2.2 Innate immunity 86
7.3 Adaptive immune responses 88
7.3.1 B cell number and function 88
7.3.2 T cell number, subtypes, and function 89
7.3.3 T cell activation, differentiation, exhaustion, and senescence 90
7.4 Consequences of immune senescence 91
7.4.1 Impaired vaccine responses, increased risk of infection, and
age-related illness 91
7.4.2 Immune senescence: A cause of aging itself 93
7.5 Conclusion 94
References 95
8 Developmental and Physiological Aging of the Lung 99
Kent E. Pinkerton, Lei Wang, Suzette M. Smiley-Jewell, Jingyi Xu, and
Francis H.Y. Green
8.1 Introduction 99
8.2 The aging lung 99
8.2.1 Alterations in lung function and anatomy 99
8.2.2 Oxidative stress and lung antioxidant defenses 101
8.2.3 Immune system changes with aging 101
8.2.4 Body mass 102
8.2.5 Airway receptor and endocrine changes with aging 103
8.3 An animal model of the aging lung: The rat 104
8.3.1 The tracheobronchial tree and epithelium of the aging rat 104
8.3.2 Parenchymal lung structure in the aging rat 105
8.3.3 Alveolar tissue compartments 106
8.4 Conclusion 110
Acknowledgments 110
References 111
9 Mouse Models to Explore the Aging Lung 117
Mingyi Wang and Deepak A. Deshpande
9.1 Pulmonary changes during aging 117
9.1.1 Advantages of mouse models for studying physiological lung changes
118
9.2 Key findings from mouse models of aging 119
9.2.1 Longevity and lung function in mice 120
9.2.2 Different strains of mice have different alterations in lung
mechanics 120
9.2.3 Transgenic mouse model to study aging in the lungs 121
9.3 Age is a risk factor for obstructive pulmonary diseases 123
9.4 Challenges ahead 124
9.5 Conclusion 125
Acknowledgments 126
References 126
10 Evidence for Premature Lung Aging of the Injured Neonatal Lung as
Exemplified by Bronchopulmonary Dysplasia 131
Anne Hilgendorff
10.1 Introducing bronchopulmonary dysplasia 131
10.2 Altered pulmonary function in infants with BPD 132
10.3 Response to injury 133
10.3.1 Oxidative stress response 134
10.3.2 Extracellular matrix remodeling 136
10.3.3 Inflammation 136
10.3.4 Morphogenetic response 137
10.4 Prenatal and genetic predisposition 137
10.5 Conclusion 138
References 138
11 Remodeling of the Extracellular Matrix in the Aging Lung 145
Jesse Roman
11.1 Introduction 145
11.2 The aging lung 145
11.3 Activation of tissue remodeling in the senescent lung 146
11.4 The aging lung fibroblast 148
11.5 Potential role of oxidant stress in triggering remodeling in the aging
lung 149
11.6 Implications for remodeling of the lung extracellular matrix in the
aged lung 150
11.7 Conclusions 152
Acknowledgments 154
References 154
12 Aging Mesenchymal Stem Cells in Lung Disease 159
Maria G. Kapetanaki, Ana L. Mora, and Mauricio Rojas
12.1 Aging and lung diseases 159
12.2 Mesenchymal stem cells (MSCs) 160
12.2.1 Description of MSCs 160
12.2.2 Characterization of MSCs 160
12.2.3 Functional properties of MSCs 161
12.3 Impact of aging on mesenchymal stem cells 162
12.3.1 In vitro aging of MSCs 162
12.3.2 Age-related changes in B-MSCs 163
12.3.3 Aging of B-MSCs versus aging of the organism 163
12.4 B-MSCs in disease 164
12.5 B-MSCs in therapy 166
12.5.1 Ex vivo expansion 166
12.5.2 Conditions affecting the expansion 167
12.5.3 Autologous versus allogeneic B-MSCs 167
12.5.4 Combination of cell preparations 167
12.5.5 Delivery and targeting 167
12.6 Conclusion 167
Acknowledgments 168
References 168
13 COPD as a Disease of Premature Aging 173
Laurent Boyer, Jorge Boczkowski, and Serge Adnot
13.1 Introduction 173
13.2 Senescent cells contribute to the pathogenesis of COPD 174
13.2.1 Accumulation of senescent cells in COPD lungs 174
13.2.2 Inflammation and lung-cell senescence in COPD 175
13.2.3 Emphysema and lung-cell senescence in COPD 176
13.2.4 Pulmonary hypertension and cell senescence in COPD 177
13.3 Lung dysfunction and the general process of premature aging in COPD
179
13.3.1 Clinical manifestations of premature aging in COPD patients 179
13.3.2 Role for lung alterations in systemic premature aging during COPD
180
13.4 Conclusion 181
References 181
14 Lung Infections and Aging 185
Jacqueline M. Kruser and Keith C. Meyer
14.1 Introduction 185
14.2 Aging and immunosenescence 185
14.2.1 Innate immunity 187
14.2.2 Adaptive immunity 188
14.2.3 Autoimmunity 189
14.2.4 Lung-specific changes in immunity with aging 190
14.3 Inflamm-aging and susceptibility to infection 190
14.4 Respiratory infection and regulation of host responses 192
14.5 Preventing respiratory infection 194
14.6 Summary and conclusions 195
References 195
Index 201